Literature DB >> 543995

Examining survival data.

A J Coldman, J M Elwood.   

Abstract

This brief review presents a nonmathematical description of the methods used to describe the outcome of patient groups when the time to an event such as death or disease recurrence is of interest. Calculation of the product-limit, actuarial and relative survival curves is described and the underlying principles are explained. Two statistical tests frequently used in comparing survival curves (the generalized Wilcoxon and the log-rank or Mantel test) are described and an example of their use is given.

Entities:  

Mesh:

Year:  1979        PMID: 543995      PMCID: PMC1705014     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

1.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

2.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

3.  On long-term relative survival rates.

Authors:  T Hakulinen
Journal:  J Chronic Dis       Date:  1977-07

4.  Survivorship: the estimation and interpretation of survival experience.

Authors:  A C Irwin
Journal:  Can Med Assoc J       Date:  1971-09-04       Impact factor: 8.262

5.  Interpreting cancer survival rates.

Authors:  J E Enstrom; D F Austin
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

6.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

7.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  7 in total
  14 in total

1.  Percutaneous transluminal angioplasty of abdominal aortic stenoses.

Authors:  A Odurny; R F Colapinto; K W Sniderman; K W Johnston
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jan-Feb       Impact factor: 2.740

2.  Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.

Authors:  R Jaeschke; G Guyatt; H Shannon; S Walter; D Cook; N Heddle
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

3.  Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

Authors:  T Trojanowski; J Peszyński; K Turowski; S Kamiński; I Gościński; M Reinfus; T Krzyszkowski; M Pyrich; A Bielawski; C Leszczyk
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

4.  Interpreting clinical trial results: seven steps to understanding.

Authors:  J M Elwood
Journal:  Can Med Assoc J       Date:  1980-09-06       Impact factor: 8.262

5.  Thyroidectomy for Graves' disease: is hypothyroidism inevitable?

Authors:  M Davenport; C H Talbot
Journal:  Ann R Coll Surg Engl       Date:  1989-03       Impact factor: 1.891

6.  Risk factors for benign breast disease: a 30-year cohort study.

Authors:  T G Hislop; J M Elwood
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

7.  Default in the outpatient treatment of tuberculosis in two hospitals in Northern India.

Authors:  J B Reed; R McCausland; J M Elwood
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

8.  Outcome of peptic ulcer hemorrhage treated according to a defined approach.

Authors:  X Mueller; J M Rothenbuehler; A Amery; B Meyer; F Harder
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Late outcome of bleeding gastric ulcers.

Authors:  H L Smart; M J Langman
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

10.  Radiation therapy for seminoma of the testis: results in British Columbia.

Authors:  S M Jackson; I Olivotto; M G McLoughlin; P Coy
Journal:  Can Med Assoc J       Date:  1980-09-20       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.